Take a look behind the scenes of a recent Future Virology article entitled ‘Latent vs productive infections: The alpha herpesvirus switch’ as we ask authors Lynn Enquist, Orkide Koyuncu and Margaret MacGibeny about latency, reactivation and the best models.
Browsing: Viral > Herpes
In this Editorial from Future Virology the authors discuss maternal immunization as a strategy for preventing neonatal HSV infection.
Scientists have revealed that a human protein – identified as YTHDF2 – could prevent cancer by restricting the human herpes virus 8, otherwise known as Kaposi’s sarcoma-associated herpesvirus.
Elucidating the effects of virus infections on the biological activity of stem cells may help improve the safety and efficacy of clinical stem cell transplantations. This study explores the underlying influence of HSV type-1 (HSV-1) infection on the energy metabolism of human umbilical cord-derived mesenchymal stem cells (UCMSCs).
Michael Pender discusses promising interim findings from a Phase 1 study investigating a novel treatment for multiple sclerosis based on the realtionship with Epstein–Barr virus.
In this exclusive opinion piece, the authors discuss how a neuroattenuated varicella zoster virus (VZV) vaccine could provide promising protection against VZV infection.
In this editorial the authors discuss how targeting the human TREX complex could prevent herpesvirus replication, highlighting their own work targeting herpesvirus lytic replication through inhibition of the hTREX complex.
Researchers have demonstrated that nanoparticles, such as those from burning fossil fuels, appear to reactivate latent herpesviruses in lung tissue.
Researchers have suggested that a virion protein known as BNRF1, produced by the Epstein–Barr Virus, may be responsible for tumor formation.